RB Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.66M | Sell |
16,083
-194
| -1% | -$69.2K | 1.2% | 19 |
|
|
2025
Q4 | $5.33M | Buy |
16,277
+257
| +2% | +$81.5K | 1.06% | 22 |
|
|
2025
Q3 | $4.52M | Buy |
16,020
+425
| +3% | +$123K | 0.93% | 26 |
|
|
2025
Q2 | $4.35M | Buy |
15,595
+320
| +2% | +$90.7K | 0.99% | 24 |
|
|
2025
Q1 | $4.76M | Buy |
15,275
+182
| +1% | +$53.7K | 1.1% | 24 |
|
|
2024
Q4 | $3.93M | Buy |
15,093
+401
| +3% | +$119K | 0.9% | 27 |
|
|
2024
Q3 | $4.73M | Buy |
14,692
+92
| +0.6% | +$30.1K | 1.1% | 22 |
|
|
2024
Q2 | $4.56M | Buy |
14,600
+447
| +3% | +$131K | 1.12% | 22 |
|
|
2024
Q1 | $4.02M | Buy |
14,153
+370
| +3% | +$108K | 1.06% | 24 |
|
|
2023
Q4 | $3.97M | Buy |
13,783
+194
| +1% | +$52.9K | 1.14% | 21 |
|
|
2023
Q3 | $3.65M | Buy |
13,589
+22
| +0.2% | +$5.49K | 1.14% | 20 |
|
|
2023
Q2 | $3.01M | Buy |
13,567
+129
| +1% | +$29.9K | 0.91% | 28 |
|
|
2023
Q1 | $3.25M | Buy |
13,438
+209
| +2% | +$51.3K | 1.03% | 21 |
|
|
2022
Q4 | $3.47M | Buy |
13,229
+92
| +0.7% | +$24.7K | 1.23% | 16 |
|
|
2022
Q3 | $2.96M | Buy |
13,137
+225
| +2% | +$54.5K | 1.13% | 20 |
|
|
2022
Q2 | $3.14M | Buy |
12,912
+276
| +2% | +$67.6K | 1.17% | 18 |
|
|
2022
Q1 | $3.06M | Buy |
12,636
+451
| +4% | +$104K | 0.98% | 24 |
|
|
2021
Q4 | $2.74M | Buy |
12,185
+399
| +3% | +$84.2K | 0.86% | 29 |
|
|
2021
Q3 | $2.51M | Buy |
11,786
+426
| +4% | +$98.1K | 0.94% | 29 |
|
|
2021
Q2 | $2.77M | Buy |
11,360
+374
| +3% | +$92K | 1.05% | 25 |
|
|
2021
Q1 | $2.73M | Buy |
10,986
+452
| +4% | +$108K | 1.21% | 19 |
|
|
2020
Q4 | $2.42M | Buy |
10,534
+484
| +5% | +$112K | 1.12% | 21 |
|
|
2020
Q3 | $2.57M | Buy |
10,050
+194
| +2% | +$48.1K | 1.21% | 20 |
|
|
2020
Q2 | $2.33M | Buy |
9,856
+410
| +4% | +$93.5K | 1.23% | 19 |
|
|
2020
Q1 | $1.97M | Buy |
9,446
+611
| +7% | +$133K | 1.27% | 19 |
|
|
2019
Q4 | $2.11M | Buy |
8,835
+388
| +5% | +$85.5K | 1.2% | 18 |
|
|
2019
Q3 | $1.67M | Buy |
8,447
+413
| +5% | +$79.3K | 1.07% | 23 |
|
|
2019
Q2 | $1.48M | Buy |
8,034
+350
| +5% | +$62.7K | 1.08% | 22 |
|
|
2019
Q1 | $1.46M | Buy |
7,684
+99
| +1% | +$18.9K | 1.19% | 21 |
|
|
2018
Q4 | $1.48M | Buy |
7,585
+432
| +6% | +$84.3K | 1.49% | 19 |
|
|
2018
Q3 | $1.48M | Sell |
7,153
-292
| -4% | -$57.5K | 1.32% | 19 |
|
|
2018
Q2 | $1.37M | Buy |
7,445
+494
| +7% | +$87.4K | 1.02% | 25 |
|
|
2018
Q1 | $1.19M | Sell |
6,951
-8
| -0.1% | -$1.47K | 0.93% | 29 |
|
|
2017
Q4 | $1.21M | Buy |
6,959
+152
| +2% | +$26.9K | 0.86% | 32 |
|
|
2017
Q3 | $1.27K | Buy |
6,807
+639
| +10% | +$113K | 0.02% | 27 |
|
|
2017
Q2 | $1.06M | Buy |
6,168
+1,143
| +23% | +$186K | 0.92% | 30 |
|
|
2017
Q1 | $824K | Sell |
5,025
-198
| -4% | -$32.9K | 0.78% | 35 |
|
|
2016
Q4 | $764K | Buy |
+5,223
| New | +$786K | 0.76% | 37 |
|
Other funds holding AMGN
VCM
VPM
RB Capital Management's AMGN Position: Q1 2026 in Review
RB Capital Management reduced its Amgen (AMGN) stake by 1.2% in Q1 2026, selling an estimated $69.2K and leaving 16,083 shares worth $5.66M. The position accounts for 1.2% of the portfolio, ranked #19.
RB Capital Management first reported a position in AMGN in Q4 2016 and has held it in 38 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- RB Capital Management held 16,083 shares of Amgen worth $5.66M as of Q1 2026.
- RB Capital Management sold 194 Amgen shares in Q1 2026, an estimated $69.2K.
- Amgen made up 1.2% of RB Capital Management's portfolio in Q1 2026, its #19 holding.
- RB Capital Management first reported a position in Amgen in Q4 2016 and has held it in 38 quarters since.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on RB Capital Management's 13F filing for Q1 2026, filed 15 May 2026.